137 related articles for article (PubMed ID: 8884351)
1. Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites.
Kaufmann O; Deidesheimer T; Muehlenberg M; Deicke P; Dietel M
Histopathology; 1996 Sep; 29(3):233-40. PubMed ID: 8884351
[TBL] [Abstract][Full Text] [Related]
2. Use of antibodies against estrogen and progesterone receptors to identify metastatic breast and ovarian carcinomas by conventional immunohistochemical and tyramide signal amplification methods.
Kaufmann O; Köther S; Dietel M
Mod Pathol; 1998 Apr; 11(4):357-63. PubMed ID: 9578086
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.
Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ
J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
Wallace ML; Longacre TA; Smoller BR
Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
[TBL] [Abstract][Full Text] [Related]
5. Metastatic adenocarcinoma to the brain: an immunohistochemical approach.
Perry A; Parisi JE; Kurtin PJ
Hum Pathol; 1997 Aug; 28(8):938-43. PubMed ID: 9269830
[TBL] [Abstract][Full Text] [Related]
6. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids.
Lee BH; Hecht JL; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2002 May; 117(5):745-50. PubMed ID: 12090423
[TBL] [Abstract][Full Text] [Related]
7. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma.
Wick MR; Ockner DM; Mills SE; Ritter JH; Swanson PE
Am J Clin Pathol; 1998 Jan; 109(1):75-84. PubMed ID: 9426521
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of breast specific antigens and cytokeratins in metastatic breast carcinoma in the liver.
Akasofu M; Kawahara E; Kurumaya H; Nakanishi I
Acta Pathol Jpn; 1993 Dec; 43(12):736-44. PubMed ID: 7509105
[TBL] [Abstract][Full Text] [Related]
9. Colon signet ring cell adenocarcinoma: immunohistochemical characterization and comparison with gastric and typical colon adenocarcinomas.
Goldstein NS; Long A; Kuan SF; Hart J
Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):183-8. PubMed ID: 10981869
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
Radhi JM
Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
[TBL] [Abstract][Full Text] [Related]
11. Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary.
Monteagudo C; Merino MJ; LaPorte N; Neumann RD
Hum Pathol; 1991 Apr; 22(4):368-72. PubMed ID: 2050370
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic immunohistochemistry of cutaneous metastatic breast carcinoma: a statistical analysis of the utility of gross cystic disease fluid protein-15 and estrogen receptor protein.
Ormsby AH; Snow JL; Su WP; Goellner JR
J Am Acad Dermatol; 1995 May; 32(5 Pt 1):711-6. PubMed ID: 7722013
[TBL] [Abstract][Full Text] [Related]
13. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
Wick MR; Lillemoe TJ; Copland GT; Swanson PE; Manivel JC; Kiang DT
Hum Pathol; 1989 Mar; 20(3):281-7. PubMed ID: 2542151
[TBL] [Abstract][Full Text] [Related]
14. Mammary origin of metastases. Immunohistochemical determination.
Chaubert P; Hurlimann J
Arch Pathol Lab Med; 1992 Nov; 116(11):1181-8. PubMed ID: 1444749
[TBL] [Abstract][Full Text] [Related]
15. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
[TBL] [Abstract][Full Text] [Related]
16. The utility of estrogen receptor and progesterone receptor immunohistochemistry in the distinction of metastatic breast carcinoma from other tumors in the liver.
Nash JW; Morrison C; Frankel WL
Arch Pathol Lab Med; 2003 Dec; 127(12):1591-5. PubMed ID: 14632573
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical characterization of neoplastic cells of breast origin.
Noriega M; Paesani F; Perazzo F; Lago N; Krupitzki H; Nieto S; Garcia A; Avagnina A; Elsner B; Denninghoff VC;
Diagn Pathol; 2012 Jun; 7():73. PubMed ID: 22726568
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte nuclear factor 4A expression discriminates gastric involvement by metastatic breast carcinomas from primary gastric adenocarcinomas.
Koyama T; Sekine S; Taniguchi H; Tsuda H; Ikegami M; Hano H; Kushima R
Hum Pathol; 2011 Nov; 42(11):1777-84. PubMed ID: 21733563
[TBL] [Abstract][Full Text] [Related]
19. Mucinous carcinoma of the eyelid. An immunohistochemical study.
Carson HJ; Gattuso P; Raslan WF; Reddy V
Am J Dermatopathol; 1995 Oct; 17(5):494-8. PubMed ID: 8599456
[TBL] [Abstract][Full Text] [Related]
20. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study.
Raju U; Ma CK; Shaw A
Mod Pathol; 1993 Sep; 6(5):516-20. PubMed ID: 8248106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
